Changing How—and When—Disease Is Found
Our Mission
Revolutionizing early disease detection with noninvasive, AI-powered urine tests, beginning with cancer
Trailblazing Innovation
Leadership Team
Matthew Laskowski
Founder, CEO & Director
Founded TOBY; led platform strategy and go-to-market at fast-growing tech companies
Joseph Hanssen
COO & Director
Co-founded Osterbury Capital; closed 30+ M&A transactions across tech, ops, risk, and finance
Scott Campit, PhD
Computational Biology
Founded Torchstack and author on 15+ metabolomics papers; PhD University of Michigan
Governance & Strategic Guidance
Board
John Leggett
Director
Co-founded Osterbury Capital; led Hamilton Research & Consulting as President for over a decade
David Joseph
Director
Public & Private company leader; Founded, funded, and scaled multiple tech and AI companies
Matthew Collier
Director
Ran Sunderland Global Services as CEO; drove digital transformation at Accenture, Bain & McKinsey
Technical Oversight
Advisory Board
Gary Slatko, MD
Advisor
Ex-FDA Office Director; three-time CMO, incl. AI cancer detection device cleared via FDA De Novo
Ian Riddington, PhD
Advisor
Director of Mass Spectrometry Facility at UT Austin; +40 years in analytical chemistry
Fueling our growth through world-class life science accelerators
Accelerators (Newest → Oldest)
Mayo Clinic & ASU
2025 MedTech Accelerator
Flagship program of the Mayo Clinic and Arizona State University Alliance for Health Care. Supports early-stage health tech companies with expert mentoring, personalized strategy, and clinical validation opportunities
Read more
Project Healthcare
Commercialization
Backed by the Nashville Entrepreneur Center, this accelerator helps healthcare startups scale by connecting them with customers, capital, and industry experts
LifeX
Pre-Commercialization
Supports early-stage healthcare companies preparing to bring science-driven technologies to market, with a focus on clinical and operational readiness
MassChallenge
Early Stage
Selected from over 1,300 startups in a globally competitive, equity-free accelerator for high-impact ventures
Grounded in Science. Guided by Purpose. Focused on You.
Our Values
Accuracy
We pursue the highest standards of precision to deliver results clinicians and patients can truly rely on
Patient First
We design every experience, from sample to result, around patient comfort, access, and empowerment
Scientific Rigor
We follow peer-reviewed science, clinical validation, and robust methodologies in everything we build
Proof that the world’s watching
Recognition (Newest → Oldest)
American Urologic Association Innovation Nexus
Selected to present at the AUA Innovation Nexus Boot Camp in DC, sharing TOBY’s vision with leading physicians at the world’s top urology society.
Massachusetts AI Health Innovation Grant
Our AI technology enhances patient care by providing data-driven insights for personalized treatment plans. This service supports healthcare providers in Massachusetts through innovative AI applications.
LEAP RECIPIENT
Selected for innovation in life sciences, gaining elite legal and strategic support for growth in cancer detection
FIRST PLACE
1st place at ADLM 2024, recognized by Mayo Clinic as the top diagnostics startup among ~100 global entrants
A Personal Search for Answers Became a Shared Solution
The Story
Matthew searched for answers to his own health issues and wondered why early detection still relied on invasive, expensive, and often inaccessible tools. That question led to the discovery of VOCs in urine: chemical signals that may reveal early signs of disease. TOBY was founded to turn those signals into simple, noninvasive, AI-powered tests, inspired by Sherlock Holmes’s scent-tracking bloodhound.